Aptevo Therapeutics Has Received A Notice Of Allowance For A U.S. Patent Titled "TUMOR-ASSOCIATED ANTIGENS AND CD3-BINDING PROTEINS, RELATED COMPOSITIONS, AND METHODS".
Benzinga Newsdesk 2 months ago
BiotechGeneralNews
Full article content is not available on this page. Continue to benzinga.com to read the original report.
